CGTX - Cognition's Alzheimer's study shows improvement in cognitive outcomes
2024-07-29 08:32:28 ET
Cognition Therapeutics ( NASDAQ: CGTX ) shares jumped in premarket trade on Monday after a mid-stage trial showed consistent improvement in cognitive outcomes with its experimental once-daily oral drug, CT1812, in mild-to-moderate Alzheimer’s patients....
Cognition’s Alzheimer’s study shows improvement in cognitive outcomes